Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01698658 · ClinicalTrials.gov registry record · NA
Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer
A NA study, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 657
- Enrollment target
NCT01698658 is a NA study that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 657 participants.
The verdict
NCT01698658, a NA study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 657 participants
- Enrollment target
Study Summary
This clinical trial studies ultrasound tomography using SoftVue in diagnosing women with breast cancer. New diagnostic procedures, such as ultrasound tomography using SoftVue, may help find and diagnose breast cancer.
Interventions
- PROCEDURE magnetic resonance imaging
- OTHER ultrasound tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 657 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-11-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01698658
The ClinicalTrials.gov registry entry for NCT01698658 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 657 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which magnetic resonance imaging is the first listed.
NCT01698658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01698658 about?
NCT01698658 is a clinical study titled "Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer". This clinical trial studies ultrasound tomography using SoftVue in diagnosing women with breast cancer. New diagnostic procedures, such as ultrasound tomography using SoftVue, may help find and diagnose breast cancer.
What is the current status of trial NCT01698658?
This trial is currently completed. It is a NA study. The enrollment target is 657 participants. The study started on 2012-10. Estimated completion is 2018-11-16.
What interventions are being tested in trial NCT01698658?
The interventions under investigation include: magnetic resonance imaging (PROCEDURE), ultrasound tomography (OTHER).
Who is sponsoring clinical trial NCT01698658?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.